{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:06:26Z","timestamp":1789740386315,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01608-5","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:36:15Z","timestamp":1789738575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-osteoporotic Pharmacotherapy and Muscle Outcomes in Osteosarcopenia: a Source-Verified Translational Evidence Map"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-1734","authenticated-orcid":false,"given":"Dong-Ju","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kue","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jocd.2009.06.004","volume":"12","author":"N Binkley","year":"2009","unstructured":"Binkley N, Buehring B (2009) Beyond FRAX: it\u2019s time to consider \u201csarco-osteopenia.\u201d J Clin Densitom 12:413\u2013416. https:\/\/doi.org\/10.1016\/j.jocd.2009.06.004","journal-title":"J Clin Densitom"},{"key":"1608_CR2","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","volume":"28","author":"HP Hirschfeld","year":"2017","unstructured":"Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781\u20132790. https:\/\/doi.org\/10.1007\/s00198-017-4151-8","journal-title":"Osteoporos Int"},{"key":"1608_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jcsm.13392","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Xu X, Gong H et al (2024) Global epidemiological features and impact of osteosarcopenia: a comprehensive meta-analysis of 66 observational studies. J Cachexia Sarcopenia Muscle 15:8\u201320. https:\/\/doi.org\/10.1002\/jcsm.13392","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1608_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"1608_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300-307.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"1608_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-019-00545-w","volume":"105","author":"C Beaudart","year":"2019","unstructured":"Beaudart C, Rolland Y, Cruz-Jentoft AJ et al (2019) Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int 105:1\u201314. https:\/\/doi.org\/10.1007\/s00223-019-00545-w","journal-title":"Calcif Tissue Int"},{"key":"1608_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","volume":"110","author":"V Chatzipetrou","year":"2022","unstructured":"Chatzipetrou V, Begin MJ, Hars M, Trombetti A (2022) Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment. Calcif Tissue Int 110:1\u201331. https:\/\/doi.org\/10.1007\/s00223-021-00898-1","journal-title":"Calcif Tissue Int"},{"key":"1608_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00223-020-00782-4","volume":"108","author":"DV Leal","year":"2021","unstructured":"Leal DV, Ferreira A, Watson EL et al (2021) Muscle-bone crosstalk in chronic kidney disease: the potential modulatory effects of exercise. Calcif Tissue Int 108:461\u2013475. https:\/\/doi.org\/10.1007\/s00223-020-00782-4","journal-title":"Calcif Tissue Int"},{"key":"1608_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","volume":"108","author":"N Carrillo-Lopez","year":"2021","unstructured":"Carrillo-Lopez N, Martinez-Arias L, Fernandez-Villabrille S et al (2021) Role of the RANK\/RANKL\/OPG and Wnt\/beta-catenin systems in CKD bone and cardiovascular disorders. Calcif Tissue Int 108:439\u2013451. https:\/\/doi.org\/10.1007\/s00223-020-00803-2","journal-title":"Calcif Tissue Int"},{"key":"1608_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00223-022-01054-z","volume":"112","author":"A Ladang","year":"2023","unstructured":"Ladang A, Beaudart C, Reginster JY et al (2023) Biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the treatment of sarcopenia: consensus paper from an expert group meeting organized by ESCEO and CARES, under the auspices of the WHO Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging. Calcif Tissue Int 112:197\u2013217. https:\/\/doi.org\/10.1007\/s00223-022-01054-z","journal-title":"Calcif Tissue Int"},{"key":"1608_CR11","doi-asserted-by":"publisher","unstructured":"Dincel AS, Jorgensen NR, on behalf of the IOF-IFCC Joint Committee on Bone Metabolism (2023) New emerging biomarkers for bone disease: sclerostin and Dickkopf-1 (DKK1). Calcif Tissue Int 112:243-257. https:\/\/doi.org\/10.1007\/s00223-022-01020-9","DOI":"10.1007\/s00223-022-01020-9"},{"key":"1608_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00223-023-01078-z","volume":"112","author":"MR Moshi","year":"2023","unstructured":"Moshi MR, Nicolopoulos K, Vreugdenburg T (2023) The clinical effectiveness of denosumab (Prolia) for the treatment of osteoporosis in postmenopausal women, compared to bisphosphonates, selective estrogen receptor modulators, and placebo: a systematic review and network meta-analysis. Calcif Tissue Int 112:631\u2013646. https:\/\/doi.org\/10.1007\/s00223-023-01078-z","journal-title":"Calcif Tissue Int"},{"key":"1608_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bone.2015.02.010","volume":"80","author":"M Brotto","year":"2015","unstructured":"Brotto M, Bonewald L (2015) Bone and muscle: interactions beyond mechanical. Bone 80:109\u2013114. https:\/\/doi.org\/10.1016\/j.bone.2015.02.010","journal-title":"Bone"},{"key":"1608_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2017.04.006","volume":"115","author":"G Karsenty","year":"2018","unstructured":"Karsenty G, Mera P (2018) Molecular bases of the crosstalk between bone and muscle. Bone 115:43\u201349. https:\/\/doi.org\/10.1016\/j.bone.2017.04.006","journal-title":"Bone"},{"key":"1608_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","volume":"18","author":"B Kirk","year":"2020","unstructured":"Kirk B, Feehan J, Lombardi G, Duque G (2020) Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep 18:388\u2013400. https:\/\/doi.org\/10.1007\/s11914-020-00599-y","journal-title":"Curr Osteoporos Rep"},{"key":"1608_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5040062","volume":"5","author":"DB Maurel","year":"2017","unstructured":"Maurel DB, Jahn K, Lara-Castillo N (2017) Muscle-bone crosstalk: emerging opportunities for novel therapeutic approaches to treat musculoskeletal pathologies. Biomedicines 5:62. https:\/\/doi.org\/10.3390\/biomedicines5040062","journal-title":"Biomedicines"},{"key":"1608_CR17","doi-asserted-by":"publisher","first-page":"14262","DOI":"10.1002\/jcb.28946","volume":"120","author":"G Li","year":"2019","unstructured":"Li G, Zhang L, Wang D et al (2019) Muscle-bone crosstalk and potential therapies for sarco-osteoporosis. J Cell Biochem 120:14262\u201314273. https:\/\/doi.org\/10.1002\/jcb.28946","journal-title":"J Cell Biochem"},{"key":"1608_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cmet.2016.05.004","volume":"23","author":"P Mera","year":"2016","unstructured":"Mera P, Laue K, Ferron M et al (2016) Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 23:1078\u20131092. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.004","journal-title":"Cell Metab"},{"key":"1608_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"1608_CR20","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC et al (2020) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18:2119\u20132126. https:\/\/doi.org\/10.11124\/JBIES-20-00167","journal-title":"JBI Evid Synth"},{"key":"1608_CR21","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 129:3214\u20133223. https:\/\/doi.org\/10.1172\/JCI125915","journal-title":"J Clin Invest"},{"key":"1608_CR22","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1172\/JCI138278","volume":"130","author":"N Bonnet","year":"2020","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2020) Corrigendum: RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 130:3329. https:\/\/doi.org\/10.1172\/JCI138278","journal-title":"J Clin Invest"},{"key":"1608_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/jcsm.13335","volume":"14","author":"L Slade","year":"2023","unstructured":"Slade L, Bollen SE, Bass JJ et al (2023) Bisphosphonates attenuate age-related muscle decline in Caenorhabditis elegans. J Cachexia Sarcopenia Muscle 14:2613\u20132622. https:\/\/doi.org\/10.1002\/jcsm.13335","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1608_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/jbmr.2162","volume":"29","author":"E Borsheim","year":"2014","unstructured":"Borsheim E, Herndon DN, Hawkins HK et al (2014) Pamidronate attenuates muscle loss after pediatric burn injury. J Bone Miner Res 29:1369\u20131372. https:\/\/doi.org\/10.1002\/jbmr.2162","journal-title":"J Bone Miner Res"},{"key":"1608_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fendo.2019.00543","volume":"10","author":"F Pin","year":"2019","unstructured":"Pin F, Bonetto A, Bonewald LF, Klein GL (2019) Molecular mechanisms responsible for the rescue effects of pamidronate on muscle atrophy in pediatric burn patients. Front Endocrinol (Lausanne) 10:543. https:\/\/doi.org\/10.3389\/fendo.2019.00543","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1608_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-024-08054-0","volume":"25","author":"W Li","year":"2024","unstructured":"Li W, Xu M, Shi X et al (2024) Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia. BMC Musculoskelet Disord 25:937. https:\/\/doi.org\/10.1186\/s12891-024-08054-0","journal-title":"BMC Musculoskelet Disord"},{"key":"1608_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00809","volume":"10","author":"AL Essex","year":"2019","unstructured":"Essex AL, Pin F, Huot JR et al (2019) Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice. Front Endocrinol (Lausanne) 10:809. https:\/\/doi.org\/10.3389\/fendo.2019.00809","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1608_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/jcsm.12289","volume":"9","author":"HC Chiu","year":"2018","unstructured":"Chiu HC, Chiu CY, Yang RS et al (2018) Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation. J Cachexia Sarcopenia Muscle 9:585\u2013602. https:\/\/doi.org\/10.1002\/jcsm.12289","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1608_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427. https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"key":"1608_CR30","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"key":"1608_CR31","doi-asserted-by":"publisher","first-page":"300060523119329","DOI":"10.1177\/03000605231193293","volume":"51","author":"A Moretti","year":"2023","unstructured":"Moretti A, de Sire A, Curci C et al (2023) Sclerostin: clinical insights in muscle-bone crosstalk. J Int Med Res 51:3000605231193293. https:\/\/doi.org\/10.1177\/03000605231193293","journal-title":"J Int Med Res"},{"key":"1608_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112869","volume":"209","author":"BC Lee","year":"2025","unstructured":"Lee BC, Kim KI, Lee J, Cho KH, Moon C (2025) Effects of resistance training on osteosarcopenia in community-dwelling postmenopausal Korean women: randomized controlled ERTO-K trial. Exp Gerontol 209:112869. https:\/\/doi.org\/10.1016\/j.exger.2025.112869","journal-title":"Exp Gerontol"},{"key":"1608_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68522-0","volume":"17","author":"GM Pagnotti","year":"2026","unstructured":"Pagnotti GM, Trivedi T, Wright LE et al (2026) Low intensity vibration with zoledronate reduces musculoskeletal weakness and adiposity in estrogen-deprived female mice. Nat Commun 17:1808. https:\/\/doi.org\/10.1038\/s41467-026-68522-0","journal-title":"Nat Commun"},{"key":"1608_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/01.gme.0000227861.35226.fa","volume":"14","author":"JJ Widrick","year":"2007","unstructured":"Widrick JJ, Fuchs R, Maddalozzo GF, Marley K, Snow C (2007) Relative effects of exercise training and alendronate treatment on skeletal muscle function of ovariectomized rats. Menopause 14:528\u2013534. https:\/\/doi.org\/10.1097\/01.gme.0000227861.35226.fa","journal-title":"Menopause"},{"key":"1608_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2016) Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149. https:\/\/doi.org\/10.1210\/en.2015-1726","journal-title":"Endocrinology"},{"key":"1608_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116029","volume":"151","author":"T Fujimaki","year":"2021","unstructured":"Fujimaki T, Ando T, Hata T et al (2021) Exogenous parathyroid hormone attenuates ovariectomy-induced skeletal muscle weakness in vivo. Bone 151:116029. https:\/\/doi.org\/10.1016\/j.bone.2021.116029","journal-title":"Bone"},{"key":"1608_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13102-020-00204-w","volume":"12","author":"DB Jepsen","year":"2020","unstructured":"Jepsen DB, Masud T, Holsgaard-Larsen A et al (2020) The combined effect of parathyroid hormone (1\u201334) and whole-body vibration exercise on physical performance in osteoporotic women: a secondary analysis from a randomized controlled trial. BMC Sports Sci Med Rehabil 12:54. https:\/\/doi.org\/10.1186\/s13102-020-00204-w","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"1608_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00774-020-01184-0","volume":"39","author":"C Sato","year":"2021","unstructured":"Sato C, Miyakoshi N, Kasukawa Y et al (2021) Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats. J Bone Miner Metab 39:385\u2013395. https:\/\/doi.org\/10.1007\/s00774-020-01184-0","journal-title":"J Bone Miner Metab"},{"key":"1608_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/gerona\/60.5.648","volume":"60","author":"A Frisoli Jr","year":"2005","unstructured":"Frisoli A Jr, Chaves PH, Pinheiro MM, Szejnfeld VL (2005) The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci 60:648\u2013653. https:\/\/doi.org\/10.1093\/gerona\/60.5.648","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1608_CR40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84726","volume":"17","author":"B Dave","year":"2025","unstructured":"Dave B, Agarawal S, Krishnan A et al (2025) Investigating the role of nandrolone decanoate in the management of osteosarcopenia in postmenopausal women: a prospective observational study. Cureus 17:e84726. https:\/\/doi.org\/10.7759\/cureus.84726","journal-title":"Cureus"},{"key":"1608_CR41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.98114","volume":"17","author":"LC Camara","year":"2025","unstructured":"Camara LC, Ferreira MH, Junior NC (2025) Nandrolone decanoate for postmenopausal osteoporosis: a systematic review and meta-analysis of randomized trials. Cureus 17:e98114. https:\/\/doi.org\/10.7759\/cureus.98114","journal-title":"Cureus"},{"key":"1608_CR42","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/jgs.16165","volume":"67","author":"S Phu","year":"2019","unstructured":"Phu S, Bani Hassan E, Vogrin S et al (2019) Effect of denosumab on falls, muscle strength, and function in community-dwelling older adults. J Am Geriatr Soc 67:2660\u20132661. https:\/\/doi.org\/10.1111\/jgs.16165","journal-title":"J Am Geriatr Soc"},{"key":"1608_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.612506","volume":"8","author":"M Pizzonia","year":"2021","unstructured":"Pizzonia M, Casabella A, Natali M et al (2021) Osteosarcopenia in very old age adults after hip fracture: a real-world therapeutic standpoint. Front Med (Lausanne) 8:612506. https:\/\/doi.org\/10.3389\/fmed.2021.612506","journal-title":"Front Med (Lausanne)"},{"key":"1608_CR44","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s10067-021-05757-w","volume":"40","author":"Y El Miedany","year":"2021","unstructured":"El Miedany Y, El Gaafary M, Toth M et al (2021) Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia? Clin Rheumatol 40:4225\u20134232. https:\/\/doi.org\/10.1007\/s10067-021-05757-w","journal-title":"Clin Rheumatol"},{"key":"1608_CR45","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00198-022-06470-3","volume":"33","author":"T Rupp","year":"2022","unstructured":"Rupp T, von Vopelius E, Strahl A et al (2022) Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study. Osteoporos Int 33:2177\u20132184. https:\/\/doi.org\/10.1007\/s00198-022-06470-3","journal-title":"Osteoporos Int"},{"key":"1608_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15135010","volume":"15","author":"SK Yetemen","year":"2026","unstructured":"Yetemen SK, Hocaoglu E, Erturk E (2026) Comparison of denosumab and bisphosphonates for sarcopenia in postmenopausal osteoporosis. J Clin Med 15:5010. https:\/\/doi.org\/10.3390\/jcm15135010","journal-title":"J Clin Med"},{"key":"1608_CR47","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s11739-024-03725-1","volume":"19","author":"A Casabella","year":"2024","unstructured":"Casabella A, Paladin F, Bighin C et al (2024) Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of denosumab versus bisphosphonates. Intern Emerg Med 19:2193\u20132199. https:\/\/doi.org\/10.1007\/s11739-024-03725-1","journal-title":"Intern Emerg Med"},{"key":"1608_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jgs.19260","volume":"73","author":"SL Greenspan","year":"2025","unstructured":"Greenspan SL, Perera S, Haeri NS et al (2025) Denosumab for osteoporosis in older adults in long-term care: a randomized trial. J Am Geriatr Soc 73:445\u2013457. https:\/\/doi.org\/10.1111\/jgs.19260","journal-title":"J Am Geriatr Soc"},{"key":"1608_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117552","volume":"198","author":"NS Haeri","year":"2025","unstructured":"Haeri NS, Perera S, Greenspan SL (2025) Impact of denosumab on muscle health in older adults in long-term care. Bone 198:117552. https:\/\/doi.org\/10.1016\/j.bone.2025.117552","journal-title":"Bone"},{"key":"1608_CR50","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2147\/CIA.S547803","volume":"20","author":"S Li","year":"2025","unstructured":"Li S, Hu S, Zheng X et al (2025) Denosumab for primary osteoporosis and its impact on sarcopenia in the Chinese population: insights from clinical evidence and RANKL pathway Mendelian randomization. Clin Interv Aging 20:2065\u20132077. https:\/\/doi.org\/10.2147\/CIA.S547803","journal-title":"Clin Interv Aging"},{"key":"1608_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114509","volume":"29","author":"S Li","year":"2026","unstructured":"Li S, Hu S, Zheng X et al (2026) Denosumab ameliorates muscle indices in Chinese osteoporosis patients through clinical and bioinformatic evidence of RANKL in sarcopenia. iScience 29:114509. https:\/\/doi.org\/10.1016\/j.isci.2025.114509","journal-title":"iScience"},{"key":"1608_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-03285-0","volume":"38","author":"C Ceolin","year":"2026","unstructured":"Ceolin C, Ziliotto C, Papa MV, Bertocco A, Sergi G, De Rui M (2026) Beyond bone effects: the role of denosumab in muscle health - a systematic review. Aging Clin Exp Res 38:46. https:\/\/doi.org\/10.1007\/s40520-025-03285-0","journal-title":"Aging Clin Exp Res"},{"key":"1608_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11657-024-01475-3","volume":"20","author":"J Ha","year":"2025","unstructured":"Ha J, Kim J, Jeong C et al (2025) Effects of denosumab and zoledronic acid on postmenopausal osteoporosis, bone density, and fat-free mass. Arch Osteoporos 20:17. https:\/\/doi.org\/10.1007\/s11657-024-01475-3","journal-title":"Arch Osteoporos"},{"key":"1608_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-025-08976-7","volume":"26","author":"RMY Wong","year":"2025","unstructured":"Wong RMY, Wong PY, Liu C et al (2025) RANK-ligand inhibition to combat sarcopenia with underlying osteoporosis: a study protocol for a randomized, double-blind, double-dummy, active-controlled trial. Trials 26:269. https:\/\/doi.org\/10.1186\/s13063-025-08976-7","journal-title":"Trials"},{"key":"1608_CR55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.14283\/jfa.2022.54","volume":"11","author":"NS Haeri","year":"2022","unstructured":"Haeri NS, Perera S, Greenspan SL (2022) Does zoledronic acid improve appendicular lean mass in older women with osteoporosis? A sub-analysis of a randomized clinical trial. J Frailty Aging 11:420\u2013425. https:\/\/doi.org\/10.14283\/jfa.2022.54","journal-title":"J Frailty Aging"},{"key":"1608_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-015-0144-7","volume":"15","author":"L Flodin","year":"2015","unstructured":"Flodin L, Cederholm T, Saaf M et al (2015) Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study. BMC Geriatr 15:149. https:\/\/doi.org\/10.1186\/s12877-015-0144-7","journal-title":"BMC Geriatr"},{"key":"1608_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/oby.70062","volume":"34","author":"S Gam","year":"2026","unstructured":"Gam S, Hermann AP, Juhl CB, Hansen SG, Gram B (2026) Effect of zoledronic acid on skeletal muscle after bariatric surgery: a secondary analysis from a randomized controlled trial. Obesity (Silver Spring) 34:76\u201387. https:\/\/doi.org\/10.1002\/oby.70062","journal-title":"Obesity (Silver Spring)"},{"key":"1608_CR58","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/DDDT.S328858","volume":"15","author":"CF Huang","year":"2021","unstructured":"Huang CF, Shiao MS, Mao TY (2021) Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients. Drug Des Devel Ther 15:3711\u20133715. https:\/\/doi.org\/10.2147\/DDDT.S328858","journal-title":"Drug Des Devel Ther"},{"key":"1608_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5114\/reum.2023.124335","volume":"61","author":"SG Al Khayyat","year":"2023","unstructured":"Al Khayyat SG, Fogliame G, Conticini E et al (2023) Effects of antiresorptive agents on body composition: a case-control retrospective study. Reumatologia (Warsz) 61:92\u201396. https:\/\/doi.org\/10.5114\/reum.2023.124335","journal-title":"Reumatologia (Warsz)"},{"key":"1608_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcsm.12390","volume":"10","author":"WJ Evans","year":"2019","unstructured":"Evans WJ, Hellerstein M, Orwoll E, Cummings S, Cawthon PM (2019) D3-creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J Cachexia Sarcopenia Muscle 10:14\u201321. https:\/\/doi.org\/10.1002\/jcsm.12390","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01608-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:36:16Z","timestamp":1789738576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01608-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01608-5","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This review synthesizes published literature and does not involve new human participant enrollment, biological material, or animal experimentation.","order":4,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted tools were used under author direction for language editing, structural consistency checks, reference deduplication, and integrity review. Deterministic scripts executed the documented searches and deduplication. The authors verified eligibility decisions, evidence classifications, extracted claims, and clinical conclusions against primary publications or stable bibliographic records and take full responsibility for the content.","order":5,"name":"Ethics","label":"AI Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"147"}}